Precigen (PGEN) Enterprise Value (2013 - 2026)

Precigen (PGEN) has reported Enterprise Value for 15 consecutive years, with -$56.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Enterprise Value fell 10.89% year-over-year to -$56.2 million; the TTM figure through Mar 2026 stood at -$56.2 million (down 10.89% YoY), while the FY2025 annual figure was -$97.9 million, down 40.41% from the prior year.
• Enterprise Value grew to -$56.2 million in Q1 2026 per PGEN's latest filing, from -$97.9 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$10.1 million in Q3 2023 and bottomed at -$121.1 million in Q3 2025.
• Historically, Enterprise Value has averaged -$63.9 million across 5 years, with a median of -$56.2 million in 2026.
• Annual changes were most pronounced in 2023 — Enterprise Value soared 88.99% — and 2025, when it plunged 323.09%.
• Precigen's Enterprise Value stood at -$56.0 million in 2022, then declined by 12.34% to -$62.9 million in 2023, then declined by 10.88% to -$69.7 million in 2024, then plunged by 40.41% to -$97.9 million in 2025, then jumped by 42.52% to -$56.2 million in 2026.
• Business Quant data shows PGEN's Enterprise Value at -$56.2 million in Q1 2026, -$97.9 million in Q4 2025, and -$121.1 million in Q3 2025.